1. Introduction {#sec1}
===============

It is known that bone mass density and architecture are intimately dependent upon mechanical factors. Several *in vitro* studies suggest that cell mechanical stimulation promotes proliferation and differentiation of osteogenic lineage \[[@B1], [@B2]\], in agreement with the results from several *in vivo* studies \[[@B3]--[@B5]\]. Bone remodeling is influenced by strain magnitude, frequency, and loading duration.

The clinical longevity and success of an implant also depend on mechanical determinants. Stress shielding causes bone loss through remodeling due to decreased loading, particularly in noncemented prostheses \[[@B6], [@B7]\]. Several solutions have been proposed for these two mechanical problems, namely, design variations and development of controlled-stiffness implants \[[@B8], [@B9]\]. A new approach to this problem, with potential application to other orthopedic problems and other medical fields, would be the development of smart implants integrating systems for bone mechanical stimulation.

The present *in vivo* study explores the use of the converse piezoelectric effect to mechanically stimulate bone with resource to Polyvinylidene Fluoride films (PVDF) (Measurement Specialties Inc Company, USA). These films were used, after dip-coating to improve cell adhesion and assure electrical insulation, as a substrate for MC3T3 cells to explore the concept of using piezoelectric materials and converse piezoelectric effect to produce effective osteoblast mechanical stimulation. The coating was performed by dip-coating at constant velocity of 0,238 mm/s. The chosen material for coating was an acrylic, poly(methyl methacrylate) (PMMA), (PERFEX, International Dental Products, USA), used alone in the first three layers and a in forth layer along with 4% of Bonelike (250--500 *μ*m) particles added (kindly offered by INESCPorto). The displacement was higher where the cells were seeded, in the central area of the coated devices, in the order of 700 nm along the *z*-axis, in a semisinusoidal fashion. On the substrates submitted to dynamic conditions, stimulation was done with an alternating sinusoidal current (AC), of 5 V, at 1 Hz and 3 Hz for 15 minutes at each frequency \[[@B10]\]. In this exploratory *in vivo* study, the same coating procedures and daily stimulation regimens were applied. The biological response around the osteotomies was assessed through histology and histomorphometry in undecalcified sections, and through histochemistry and immunohistochemistry in decalcified sections, namely, through Masson\'s trichrome, and labeling of osteopontin (OPN), proliferating cell nuclear antigen (PCNA), and tartrate-resistant acid phosphatase (TRAP).

2. Materials and Methods {#sec2}
========================

2.1. Actuator Device Design and Sterilization {#sec2.1}
---------------------------------------------

The actuator device was composed of a microboard containing an ultra-low power 16-bit microcontroller (eZ430-RF2500, Texas Instruments, USA), powered by lithium battery and encapsulated in PMMA and a set of six actuators composed of polyvinylidene fluoride (PVDF) and silver electrodes, electrically insulated by dip-coating as described elsewhere \[[@B10]\]. Each actuator measured 15 mm width and 40 mm length, with an active area of 12 × 31 mm^2^. The actuator device was programmed to apply a 5 V square wave of 1 Hz and 3 Hz for 15 minutes at each frequency, once every 24 hours.

Finite Numerical Method studies and Electronic Speckle Pattern Interferometry Process (ESPI) studies have shown the lower deformation levels occurred in the clamped region of the films, for a potential differential of 5 V, and the higher deformation occurred in the opposite extremity of the film \[[@B10]\].

A control device, similar but static was also developed. A sterilization method was developed and validated based on ISO 11737-1 and ISO 14937, using a series of decontaminating solutions (10% sodium hypochlorite for 20 minutes, without agitation, washing in sterile water, and immersion in 10% hydrogen peroxide for 30 minutes, without agitation, followed by rinse in sterile water and drying under laminar flux), before 2 hours of exposure to UV (in two different positions).

2.2. Surgical Procedure {#sec2.2}
-----------------------

The actuator device was implanted in the left hind limb, and a control device was implanted in the right hind limb, of a 4-year-old merino ewe, with 45 kg body-weight.

The animal was premedicated with atropine (0.7 mg/kg), xylazine (0.1 mg/kg) and butorphanol (0.01 mg/kg), and anesthesia induced with thiopental sodium 5% (5 mg/kg) by intravenous injection. The anesthesia was maintained through isoflurane with spontaneous ventilation.

The stifle joint of both legs was prepared with a solution of povidone-iodine and ethanol 70%, after being shorn and shaved. Two longitudinal incisions were made on the craniomedial border of the femur and at tibial crest level. The tibial bone was exposed by reflecting deep medial fascia, the vastus medialis and cranial part of the sartorius muscles and the periosteum, and two osteotomies were made using an especially metal designed guide to make two regular and well-orientated osteotomies using an oscillating saw. The bone was continuously irrigated with a sterile saline solution during the process of low-speed drilling and cutting. The same procedure was followed with a different design guide for the distal femoral physis, where four osteotomies were done. The osteotomies were made perpendicularly to the long axis of the bone.

A stab wound was made in the fascia lata, and the extremities of the piezoelectric films passed through it, and then, the active area of each piezoelectric film was placed inside the slot osteotomy cavity. The actuator position inside the tibial bone can be clearly viewed in [Figure 1(a)](#fig1){ref-type="fig"}, obtained post-mortem. The portion of the device containing the microprocessor and the power supply was left in the nearby subcutaneous space.

The actuator device was implanted in the left hind limb, and control on the right hind limb. After placing the implants, incisions were closed routinely with a continuous-pattern suture in the retinaculum and fascia, using absorbable Surgicryl 2/0 (SMI AG, Belgium) and in the skin with Silk 0 (SMI AG).

Postoperative X-ray images were obtained thirty days after implantation, before sacrifice, to ensure the proper evolution of the bone cuts and to detect signs of infection/inflammation ([Figure 2](#fig2){ref-type="fig"}).

One week after implantation calcein (15 mg/kg; Sigma, USA) was injected subcutaneously and one week prior to sacrifice the same procedure was done with alizarin complexone (25 mg/kg; Sigma, USA). Thirty days after implantation, the ewe was sacrificed by intravenous sodium pentobarbital injection.

The present study was authorized by competent national authorities and conducted accordingly to FELASA\'s guidelines for animal care.

2.3. Tissue Processing, Histology, and Immunohistochemistry {#sec2.3}
-----------------------------------------------------------

Both hind limbs were dissected, the implanted materials and surrounding tissue removed and fixed in 4% paraformaldehyde for two weeks. Bone samples were cut transversally to the long axis of the bone, each including a piezoelectric film and the surrounding bone ([Figure 1(a)](#fig1){ref-type="fig"}).

Specimens were dehydrated through an ascending ethanol series. Soft tissues (local lymph nodes and samples of the fibrous capsule surrounding the implants) were routinely processed and embedded in paraffin. Undecalcified bone samples of each of the implants were included in resin (Technovit 9100, Heraeus Kulzer, Germany) according to the manufacturer\'s instructions and 80 *μ*m thick sections cut with a saw microtome (Leica 1600, Germany) parallel to the piezoelectric film long axis. A minimum of five sections of each resin block was cut. Sections were then appropriately processed for routine staining (Giemsa Eosin), mounted for fluorescence microscopy. The prepared slides were evaluated qualitatively. For histomorphometric studies, the interface between the bone and implant was divided in four distinct areas: Z1, Z2, Z3, and Z4, from cortical towards bone surrounding the free extremity of the piezoelectric film ([Figure 1(b)](#fig1){ref-type="fig"}). Pictures were taken from the bone surrounding both sides of the film in areas Z1 to Z3 and Z4, using a 40x magnification ([Figure 3](#fig3){ref-type="fig"}).

For immunohistochemistry and histochemistry, bone sections were decalcified in formic acid 5% for 3 weeks, dehydrated in ethanol, cleared in xylene, and embedded in paraffin wax and 3 *μ*m sections cut. After deparaffinization and rehydration, immunohistochemistry sections were treated with 3% hydrogen peroxide for 10 minutes. Primary antibodies for Tartrate-Resistant Acid Phosphatase (TRAP) (Thermo Scientific, USA, mouse monoclonal antibody, Ab-1, Clone 26E5, Cat. no.MS-1768), Proliferating Cell Nuclear Antigen (PCNA) (NeoMarkers, USA, mouse monoclonal antibody, Ab-1, Clone PC10, Cat. no.MS-106-P0), and Osteopontin (NeoMarkers, rabbit polyclonal antibody, Cat. no.RB-9097) were diluted to 1 : 20, 1 : 200, and 1 : 50, respectively. Prior to immunostaining, the sections were pretreated for antigen retrieval at 100°C in 10 mM citrate buffer, pH 6, for 20 minutes in microwave oven, followed by cooling for 30 minutes at room temperature. For double staining of PCNA and osteopontin, immunohistochemistry was done using a double staining kit *PicTure* (Zymed Laboratories Inc, USA), according with the manufacturer\'s instructions. Slides were counterstained with Mayer\'s hematoxylin and Clearmount used to mount the slides. TRAP immunohystochemistry was performed with resource to kit *PicTure*-MAX Polymer (Invitrogen, USA). Slides were counterstained with Mayer\'s hematoxilin, dehydrated, mounted with Entellan (Merck, Germany), and coverslipped.

For all sections, positive controls were made simultaneously. As negative controls adjacent sections were incubated: (a) without primary antibody and (b) with rabbit/rat normal serum (similar concentration as that of primary).

Masson Trichrome was done using a kit (Bio-Optica, Italy), followed by dehydration and mounting.

Observation and pictures were done using optic (Olympus BX41) and fluorescence microscope equipped with WB Fluorescence cube (Olympus U-LH100HG).

2.4. Statistical Analysis {#sec2.4}
-------------------------

Total bone area, immature bone area, and mature bone area were measured using Sigma ScanPro 5 (Systat Software Inc., USA). The results, in percentage of total bone area, mature bone, and immature bone, were determined for each piezoelectric film in the pre-determined areas Z1 to Z4. Capsule thickness was measured with resource to cell^∧^A software (Olympus, Germany). Normal distribution of the results was verified using the Kolmogorov-Smirnov test, homogeneity of variance assessed through the Levene test, and differences between groups tested using one-way ANOVA (at a 0.05 level). The statistical analysis was done using software OriginPro 8 (OriginLab Corporation, USA).

3. Results {#sec3}
==========

After one-month implantation period, there were statistically significant differences. Total bone area around the actuators was significantly higher, when comparing to static controls (39.91 ± 14.08% versus 27.20 ± 11.98%) ([Figure 4](#fig4){ref-type="fig"}).

The increment of bone occupied area was due to new bone formation, and in actuators the area occupied by woven bone and osteoid was 64.89 ± 19.32% of the total bone area versus 31.72 ± 14.54% in static devices ([Figure 5](#fig5){ref-type="fig"}). The chosen staining technique, Giemsa Eosin, stains older bone in a darker shade of pink, whilst more recently deposed bone is of a lighter pink color and frequently adjacent to much less prominent osteoid (dark blue) areas (Figures [5(a)](#fig5){ref-type="fig"} and [5(b)](#fig5){ref-type="fig"}). Taking into account the close relation in between osteoid and woven, recently formed bone, the authors chose not to make separated measurements that could be misleading. The bone marrow present in the sections showed no relevant alterations.

The deposition of new bone was more marked in certain areas of the devices. The significant differences arise from the bone areas surrounding the two distal thirds of the devices; around the devices\' clamped area, no differences were found between actuated and static devices ([Figure 6](#fig6){ref-type="fig"}).

When assessing the mineral apposition rate in the distal third of the films, with the aid of the fluorochrome labeling, the mineral apposition rate was significantly higher around actuated devices (4.44 ± 1.67 *μ*m/day) than around static devices (2.70 ± 0.95 *μ*m/day) ([Figure 5](#fig5){ref-type="fig"}).

A fibrous capsule was obvious both in actuators and static devices, with no statistical significant differences in capsule thickness between the two groups (289.59 ± 131.20 *μ*m in actuated films versus 293.93 ± 84.79 *μ*m). The average thickness of the capsule was of 292 *μ*m.

Immunohistochemistry failed to detect differences in TRAP expression between the two groups, but there is a marked elevation in OPN detection around actuators, in Z3 and Z4 ([Figure 7](#fig7){ref-type="fig"}). OPN is also strongly labeled in the fibroblast layers closer to the PVDF films, both in actuators and static controls, and this is the area where positive PCNA labeling was found more often. PCNA labeling was also positive in some of the preosteoblastic cells in layers apposed to OPN-positive columnar osteoblasts.

4. Discussion {#sec4}
=============

The existence of micro-movements at the interface, depending on the magnitude, may enhance osteogenesis or impair it and promote the formation of fibrous tissue \[[@B11], [@B12]\]. Considering the deformation levels of the actuator devices, under the experimental conditions, the generated strains were low, but the results suggest they are enough to elicit response.

Mineral apposition rate and total bone mass are significantly higher around actuated films when compared to static controls, and these differences arise from around the areas of the films known to have higher displacement values.

The increased OPN expression we found around actuators when comparing to static controls is most likely associated with mechanical stress, and it was not accompanied by a proportional increase in TRAP. OPN is a multifunctional noncollagenous glycoprotein present in bone matrix, expressed in various degrees by proliferating preosteoblasts, osteoblasts, and osteocytes but also by fibroblasts, osteoclasts, and macrophages \[[@B13]--[@B15]\]. OPN production is known to be increased in association with mechanical loading \[[@B15], [@B16]\], and its deficiency significantly decreases bone fracture toughness, leading to heterogeneous mineral distribution, since OPN is known to bind strongly to hydroxyapatite, and cell surface as well \[[@B17], [@B18]\].

However, a few questions arise. The first is related to PVDF\'s biocompatibility. We observed that all the devices were separated from neighboring bone by a fibrous capsule. This is probably due to the material itself, since there were no differences between actuators and static controls. It would be mandatory to develop and test a material with improved biocompatibility to evaluate accurately the bone material interface.

One other issue arises from reflecting upon the material and the coating properties and behavior. The *in vitro* study previously developed shows evidence of adequate electric insulation for 48 hours in the experimental conditions \[[@B10]\].

However, the *in vivo* environment is not as controlled and, in addition to a longer period of time, the implantation procedure itself may induce damage on the coating. If coating damage occurs, one should consider the possible effects of the material (PVDF and silver nitrate particles from the electrode) and electrical current. Previous studies have shown cytotoxic silver nitrate activity, dependent on the concentration \[[@B19], [@B20]\].

The possible creation of electric field locally and its effects are more complex. The clinical advantages of applying electrical and electromagnetic fields in the treatment of fractures and mal-unions have been long known although the mechanisms leading to the clinical response are not well understood \[[@B21]--[@B23]\]. Electric fields as low as 0.1 mV/cm promote osteoblast proliferation, with cell metabolic activity being influenced by the intensity of the electric field, and cell signaling based on the voltage-dependent calcium channels \[[@B24], [@B25]\]. Electric and electromagnetic fields also exert effects on fibroblasts, enhancing proliferation, protein synthesis and influencing cell alignment, by calcium-independent mechanisms \[[@B26]--[@B29]\]. The fact that we found no significant differences in fibrous capsule thickness surrounding the devices suggests it is likely that the electric insulation remained satisfactory, but further studies would be needed to prove this. However, if an electric field was being created locally, increased bone formation along the whole actuator could also be expected. Instead, new bone formation follows a pattern in accordance with what is known to be the areas of increased motion and deformation.

This study was performed in one animal only but using an adequate number of devices (total of twelve). The sheep was chosen as an animal model considering the bone biology similarities with the human species and the size of the devices. The results are very clear in evidencing qualitative and quantitative statistically significant differences when comparing static and actuated films, but it would be necessary to enlarge the animal study and to study response with longer implantation times. However, from an ethical point of view, it would be desirable to do so after developing a material other than PVDF, more biocompatible.

5. Conclusions {#sec5}
==============

In conclusion, the present *in vivo* study suggests that in fact piezoelectric materials and the converse piezoelectric effect may be used to effectively stimulate bone growth at the bone implant interface, eliciting an early response. Piezoelectric materials have the advantages of enabling a wide range of deformation/displacement, frequencies, and regimens. Therefore, they are excellent candidate components of actuators for clinical purposes. However, new materials should be developed, aiming better biocompatibility.
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![Location of the actuators within the bone. The figure shows example of bone section prior to inclusion: (a) section of tibia---scale bar 1 cm; (b) shows how the areas for histomorphometry were distributed; Z1 corresponds to the film clamped region---scale bar 2 cm.](JBB2012-613403.001){#fig1}

![Postoperative radiograph thirty days after implantation showing the six actuators in place (four in the femur, two in the tibia). There are neither signs of periostal or peri-implantar reaction nor signs of infection in neighboring soft tissues.](JBB2012-613403.002){#fig2}

![Low-magnification picture of histological section where it is evident the fibrous tissue around the implant (arrows). Scale bar represents 4 mm.](JBB2012-613403.003){#fig3}

![Total bone area measured around actuators and static controls, expressed in percentage. Bars represent means and error bars standard deviation.](JBB2012-613403.004){#fig4}

![Microphotograph of nondecalcified sections. On top, (a) shows Z3 areas of actuator and (b) shows static control, both implanted in the same position in tibia. On bottom, Z2 areas showing increase labeled area in (c) femoral actuator when compared to contra lateral (d) static control. A fibrous capsule (FC) was present on the bone/film interface. Scale bar represents 200 *μ*m.](JBB2012-613403.005){#fig5}

![Total bone area measured around actuators and static controls, organized by areas Z1 to Z4. Bars represent means and error bars standard deviation.](JBB2012-613403.006){#fig6}

![Microphotograph of decalcified sections, osteopontin (white arrows) and PCNA expression. Picture shows Z3 areas of femoral: (a) actuator and (b) static control, suggesting more extensive osteopontin labeling around actuator. Double Fast-Red and DAB immunohistochemistry staining for osteopontin and PCNA, respectively. Scale bar represents 100 *μ*m.](JBB2012-613403.007){#fig7}
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